Akme Fintrade (India) Ltd

Quick check

The five things to look at first. Open one for more.

• DebtModerate safety, with cautionRated A- to BBB+ by 3 agencies.
• ResultsGrowingIn the Jun 2026 quarter, sales rose 31% and profit rose 20% from a year earlier.
• DilutionSome dilutionIssued 1.3 crore new shares in the last year, raising ₹11.33 Cr.
• PromotersPromoters sellingThe promoters (founders or parent) own 39%, down from 41% in Jun 2025.
• ValuationCheap vs its pastThe share trades at 7.3 times its yearly earnings (P/E), cheaper than 93% of the time in the last 2 years. Its usual P/E is about 10.

Akme Fintrade (India) Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

• Valuation (P/E)7.3 against a typical 22.5: cheaper than most peers (1st = cheapest).41st of 284
• Sales growth+31.3% against a typical +18.3% from a year earlier.109th of 259
• Profit growth+20% against a typical +20.2% from a year earlier.108th of 214
• Share price, 3 months−21.5% against a typical −4.2%.220th of 258

Exchange filings and their impact on the company.

• 26 Oct 2026General UpdatesMedium impactPositivePrice +3.5% on 27 Oct
  Indian Overseas Bank sanctioned a Rs 50 cr term loan to fund loan-book growth.

  Akme Fintrade (India) Limited informed that Indian Overseas Bank has sanctioned a term loan of Rs 50 crore to the company. The intimation was filed on October 26, 2026. For an NBFC with borrowings of Rs 503 crore, the facility provides fresh funding to expand its loan book and support growth over the next year.

  Full analysisFiling
• 19 Oct 2026Outcome of Board MeetingMedium impactPositivePrice −6.5% that day
  Allotted Rs 50 cr secured NCDs at 11.4-11.6% to fund lending growth.

  Akme Fintrade's board on October 19, 2026 allotted 50,000 secured, listed, rated NCDs of Rs 10,000 each totalling Rs 50 crore on private placement. Series A1 of Rs 25 crore carries 11.40% coupon for 24 months to October 2028 and Series A2 of Rs 25 crore carries 11.60% coupon for 30 months to April 2029, with monthly interest and 1.10x cover on loan receivables. The funds add about 10% to borrowings and will support loan-book growth, adding interest cost of about Rs 5.75 crore per year.

  Full analysisFiling
• 10 Oct 2026Outcome of Board MeetingMedium impactPositivePrice +5.7% on 12 Oct
  Board approved Rs 50 cr secured NCDs to fund loan-book growth, lifting debt ~10%.

  Akme Fintrade's board on October 10, 2026 approved issue of secured, listed, rated NCDs up to Rs 50 crore in Series A1 (Rs 25 crore, up to 24 months) and Series A2 (Rs 25 crore, up to 30 months) on private placement basis. It also authorised the Loan & Investment Committee to decide terms for NCD issuance up to Rs 300 crore. The money will add to borrowings to fund the NBFC's loan book, supporting interest income growth over the next year with higher leverage but no equity dilution.

  Full analysisFiling
• 6 Oct 2026Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvalsLow impactPositivePrice −4.6% on 7 Oct
  13 lakh warrants converted bring Rs 11.3 cr at above-market prices, lifting net worth ~2.7% with ~3% dilution.

  Akme Fintrade received listing and trading approval for 1.3 crore new shares issued on conversion of preferential warrants. This includes 30 lakh shares at Rs 11.10 each and 1 crore shares at Rs 8.00 each, all to non-promoters, bringing in about Rs 11.33 crore. The shares will trade from October 6, 2026, modestly strengthening capital for loan growth with about 3% equity dilution.

  Full analysisFiling

Results dates and other board meetings. Full calendar

Compounded yearly rates over each period.